# Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy

> **NCT02246023** · PHASE4 · COMPLETED · sponsor: **Daniel Franzen** · enrollment: 78 (actual)

## Conditions studied

- Lung Cancer
- Sarcoidosis
- Interstitial Pneumonia

## Interventions

- **DEVICE:** Flexible bronchoscopy in moderate sedation
- **DEVICE:** Oxygen saturation
- **DEVICE:** Blood pressure
- **DEVICE:** Propofol dosage
- **DEVICE:** Recovery time after bronchoscopy

## Key facts

- **NCT ID:** NCT02246023
- **Lead sponsor:** Daniel Franzen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2016-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02246023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02246023, "Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02246023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*